PHI with Peripheral artery atherosclerosis
How does this condition affect your private health insurance?
Atherosklerose der Extremitätenarterien, also known as Peripheral Artery Disease (PAD), is a chronic circulatory condition where arteries supplying blood to the limbs, most commonly the legs, become narrowed due to the buildup of fatty plaques. This restricts blood flow, leading to symptoms like intermittent claudication—pain or cramping in the legs during exercise that subsides with rest. As the disease progresses, patients may experience numbness, coldness, and non-healing sores. Severe cases can result in critical limb ischemia, gangrene, and necessitate amputation. Risk factors include smoking, diabetes, high blood pressure, and high cholesterol. Early diagnosis and lifestyle modifications are crucial for management.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several months to years, with initial symptoms often subtle and worsening over time.
Duration of Illness (Lifetime)
Chronic and progressive, lifelong management required.
Cost of Treatment (Initial)
Moderate (diagnosis, medication) to high (interventional procedures) depending on severity at diagnosis.
Cost of Treatment (Lifetime)
High, due to chronic medication, potential for multiple interventions, and management of complications.
Mortality Rate
Increased, primarily due to associated cardiovascular and cerebrovascular diseases; direct mortality from limb complications is also a factor if untreated.
Risk of Secondary Damages
High, including critical limb ischemia, chronic pain, non-healing ulcers, gangrene, and amputation; significant impact on quality of life and psychological well-being.
Probability of Full Recovery
Low; the underlying atherosclerosis is chronic, but symptoms can be managed, and progression can be slowed with treatment.
Underlying Disease Risk
High, commonly co-occurs with coronary artery disease, cerebrovascular disease, hypertension, diabetes mellitus, and hyperlipidemia.